Ekso Total Assets from 2010 to 2024
EKSO Stock | USD 1.26 0.01 0.80% |
Total Assets | First Reported 2012-06-30 | Previous Quarter 31.2 M | Current Value 28.9 M | Quarterly Volatility 14.8 M |
Check Ekso Bionics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ekso main balance sheet or income statement drivers, such as Interest Expense of 271.3 K, Selling General Administrative of 8.7 M or Other Operating Expenses of 28.5 M, as well as many exotic indicators such as Price To Sales Ratio of 1.8, Dividend Yield of 0.11 or PTB Ratio of 2.61. Ekso financial statements analysis is a perfect complement when working with Ekso Bionics Valuation or Volatility modules.
Ekso | Total Assets |
Latest Ekso Bionics' Total Assets Growth Pattern
Below is the plot of the Total Assets of Ekso Bionics Holdings over the last few years. Total assets refers to the total amount of Ekso Bionics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Ekso Bionics Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Ekso Bionics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ekso Bionics' overall financial position and show how it may be relating to other accounts over time.
View | Last Reported 28.92 M | 10 Years Trend |
|
Total Assets |
Timeline |
Ekso Total Assets Regression Statistics
Arithmetic Mean | 22,221,136 | |
Geometric Mean | 3,898,854 | |
Coefficient Of Variation | 72.26 | |
Mean Deviation | 12,707,428 | |
Median | 24,425,000 | |
Standard Deviation | 16,056,057 | |
Sample Variance | 257.8T | |
Range | 49.2M | |
R-Value | 0.69 | |
Mean Square Error | 146.7T | |
R-Squared | 0.47 | |
Significance | 0 | |
Slope | 2,465,597 | |
Total Sum of Squares | 3609.2T |
Ekso Total Assets History
Other Fundumenentals of Ekso Bionics Holdings
Ekso Bionics Total Assets component correlations
Click cells to compare fundamentals
About Ekso Bionics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Ekso Bionics income statement, its balance sheet, and the statement of cash flows. Ekso Bionics investors use historical funamental indicators, such as Ekso Bionics's Total Assets, to determine how well the company is positioned to perform in the future. Although Ekso Bionics investors may use each financial statement separately, they are all related. The changes in Ekso Bionics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ekso Bionics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ekso Bionics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ekso Bionics. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Total Assets | 28.9 M | 26 M | |
Intangibles To Total Assets | 0.18 | 0.19 |
Pair Trading with Ekso Bionics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ekso Bionics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekso Bionics will appreciate offsetting losses from the drop in the long position's value.Moving together with Ekso Stock
0.77 | AHG | Akso Health Group Earnings Call Today | PairCorr |
Moving against Ekso Stock
0.93 | SNDA | Sonida Senior Living | PairCorr |
0.86 | TNDM | Tandem Diabetes Care Financial Report 1st of May 2024 | PairCorr |
0.84 | JYNT | Joint Corp Financial Report 2nd of May 2024 | PairCorr |
0.71 | TLIS | Talis Biomedical Corp | PairCorr |
0.69 | GCTK | GlucoTrack | PairCorr |
The ability to find closely correlated positions to Ekso Bionics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ekso Bionics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ekso Bionics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ekso Bionics Holdings to buy it.
The correlation of Ekso Bionics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ekso Bionics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ekso Bionics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ekso Bionics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Ekso Bionics Correlation against competitors. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Ekso Stock analysis
When running Ekso Bionics' price analysis, check to measure Ekso Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ekso Bionics is operating at the current time. Most of Ekso Bionics' value examination focuses on studying past and present price action to predict the probability of Ekso Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ekso Bionics' price. Additionally, you may evaluate how the addition of Ekso Bionics to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Ekso Bionics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.10) | Revenue Per Share 1.318 | Quarterly Revenue Growth 0.365 | Return On Assets (0.27) | Return On Equity (0.80) |
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.